Pharmacokinetics and pharmacodynamics in the critically ill patient

References

• Aitken H. A., Burns J. W., Mc Cardle C. S., Kenny G. N. C. Effects of keterolac trometalol on renal function. British Journal of Anaesthesia 1992; 68: 481–485
   PubMed Web of Science ®Google Scholar
• Aitkenhead A. R., Vater M., Achola K., Cooper C. M. S., Smith G. Pharmaco-kinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure. British Journal of Anaesthesia 1984; 56: 813–817
   PubMed Web of Science ®Google Scholar
• Alazia M., Levron J. C., Quidon C., Francois G. Pharmacokinetics of fentanyl during continuous infusion in critically ill patients. Anesthesiology 1987; 67: A665
   PubMed Web of Science ®Google Scholar
• Allonen H., Zeigler G., Klotz U. Midazolam kinetics. Clinical Pharmacology and Therapeutics 1981; 30: 653–661
   PubMed Web of Science ®Google Scholar
• Amos R. J., Amess J. A. L., Hinds C. J., Mollin D. L. Incidence and pathogenesis of acute bone megaloblastic marrow change in patients receiving intensive care. Lancet 1982; ii: 835–837
   Google Scholar
• Andree R. A. Sudden death following naloxone administration. Anesthesia and Analgesia 1980; 59: 782–784
   PubMed Web of Science ®Google Scholar
• Angus P. W., Morgan D. J., Smallwood R. A. Review article. Hypoxia and hepatic drug metabolism—clinical implication. Alimentary Pharmacology and Therapeutics 1990; 4: 213–225
   PubMed Web of Science ®Google Scholar
• Arai K., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annual Review of Biochemistry 1990; 59: 783–836
   PubMed Web of Science ®Google Scholar
• Arduino M. J., Bland L. A., Mc Allister S. K., Aguero S. M., Villarino M. E., Jarvis W. R., Favero M. S. Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infection Control and Hospital Epidemiology 1991; 12: 535–539
   PubMed Web of Science ®Google Scholar
• Armstrong S. G., Renton K. W. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice. Molecular Pharmacology 1993; 43: 542–547
   PubMed Web of Science ®Google Scholar
• Arnold J. H., Truog R. D., Orav E. J., Scavone J. M., Hershenson M. B. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 1990; 73: 1136–1140, Abs.
   PubMed Web of Science ®Google Scholar
• Arnold J. H., Truog R. D., Scavone J. M., Fenton T. Changes in the pharmaco-dynamic response to fentanyl in neonates during continuous infusion. Journal of Pediatrics 1991; 119: 639–643
   PubMed Web of Science ®Google Scholar
• Bailey P. L., Pace N. L., Ashburn M. A., Moll J. W. B., East K. A., Stanley T. H. Frequent hypoxemia and apnoea after sedation with midazolam and fentanyl. Anesthesiology 1990; 73: 826–830
   PubMed Web of Science ®Google Scholar
• Bakle Y. S. First pass metabolism of endogenous and exogenous substrates by lung. Presystemic Drug Elimination, C. F. George, D. G. Shand. Butterworths, London 1982; 147–172
   Google Scholar
• Ball M., Mc Quay H. J., Moore R. A., Allen M. C., Fisher A., Sear J. Renal failure and the use of morphine in intensive care. Lancet 1985; i: 784–786
   Google Scholar
• Barnes J. N., Williams A. J., Toseland P. A., Goodwin F. J. Opioid drugs and renal failure. Lancet 1984; ii: 748
   Google Scholar
• Barson A. J., Chiswick M. L., Doig C. M. Fat embolism in infancy after intravenous fat infusions. Archives of Disease in Childhood 1978; 53: 218–223
   PubMed Web of Science ®Google Scholar
• Beck F. J., Whitehouse M. W. Impaired drug metabolism in rats associated with acute inflammation: a possible assay for anti-injury agents. Proceedings of the Society for Experimental Biology and Medicine 1974; 145: 135–140
   PubMed Web of Science ®Google Scholar
• Becker G. L. Effects of nonvolatile agents on oxygen demand and energy status in isolated hepatocytes. Anesthesia and Analgesia 1988; 67: 923–928
   PubMed Web of Science ®Google Scholar
• Becker G. L., Miletich D. J., Albrecht R. F. Halogenated anesthetics increase oxygen consumption in isolated hepatocytes from phenobarbital-treated rats. Anesthesiology 1987; 67: 185–190
   PubMed Web of Science ®Google Scholar
• Belin R. P., Bivins B. A., Jona J. Z., Young V. L. Fat overload with a 10% Soybean oil emulsion. Archives of Surgery 1976; 111: 1391–1393
   PubMedGoogle Scholar
• Bianchetti G., Graziani G., Branicaccio D. Pharmacokinetics and effects of propanolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clinical Pharmacokinetics 1976; 1: 373–384
   PubMedGoogle Scholar
• Bion J. F., Logan B. K., Newman P. M., Brodie M. J., Oliver J. S., Aitchison T. C., Ledingham I. M. Sedation in intensive care: morphine and renal function. Intensive Care Medicine 1986; 12: 359–365
   PubMed Web of Science ®Google Scholar
• Bodenham A., Brownlie G., Dixon J. S., Park G. R. Reversal of sedation by prolonged infusion of flumazenil. Anaesthesia 1988a; 43: 376–378
   PubMed Web of Science ®Google Scholar
• Bodenham A., Quinn K., Park G. R. Extra-hepatic metabolism of morphine. British Journal of Anaesthesia 1989; 63: 380–384
   PubMed Web of Science ®Google Scholar
• Bodenham A., Park G. R. Alfentanil infusions in patients requiring intensive care. Clinical Pharmacokinetics 1988; 15: 216–226
   PubMed Web of Science ®Google Scholar
• Bodenham A., Park G. R. Reversal of prolonged sedation using flumazenil in critically ill patients. Anaesthesia 1989; 44: 603–605
   PubMed Web of Science ®Google Scholar
• Bodenham A., Shelly M. P., Park G. R. The altered pharmacokinetics and pharmaco-dynamics of drugs commonly used in critically ill patients. Clinical Pharmacokinetics 1988b; 14: 347–373
   PubMed Web of Science ®Google Scholar
• Bonnet F., Richard C., Glaser P., Lafay M., Guesde R. Changes in hepatic flow induced by continuous positive pressure ventilation in critically ill patients. Critical Care Medicine 1982; 10: 703–705
   PubMed Web of Science ®Google Scholar
• Bower S., Hull C. J. Comparative pharmacokinetics of fentanyl and alfentanil. British Journal of Anaesthesia 1982; 54: 871–877
   PubMed Web of Science ®Google Scholar
• Bower S., Sear J. W., Roy R. C., Carter R. F. Effects of different hepatic pathologies on disposition of alfentanil in anaesthetized patients. British Journal of Anaesthesia 1992; 68: 462–465
   PubMed Web of Science ®Google Scholar
• Boyle W. A., Shear J. M., White P. F., Schuller D. Tolerance and hyperlipemia during long-term sedation with propofol. Anesthesiology 1990; 73: A245, Suppl.
   Google Scholar
• Brater D. C. Disposition and response to bumetanide and furosemide. American Journal of Cardiology 1986; 57: 20A–25A
   PubMed Web of Science ®Google Scholar
• Burns A. M., Park G. R. A comparison of EDTA and creatinine clearance as measures of renal function after liver transplantation. Anaesthesia 1993, in press
   PubMed Web of Science ®Google Scholar
• Burns A. M., Shelly M. P., Walker S., Park G. R. Serum acute phase proteins after orthotopic liver transplantation. British Journol of Anaesthesia 1990; 65: 418–420
   PubMed Web of Science ®Google Scholar
• Byatt C. M., Lewis L. D., Dawling S., Cochrane G. M. Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit. British Medical Journal 1984; 289: 799–800
   PubMed Web of Science ®Google Scholar
• Campos R. A., Herraez F. X. V., Marcos R. J., Amer J. G., Porcar R. C., Lucia P. I. Drug use in an intensive care unit and its relation to survival. Intensive Care Medicine 1980; 6: 163–168
   PubMed Web of Science ®Google Scholar
• Carrupt P. A., Testa B., Bechalany A., El Tayar N., Descas P., Perrissoud D. Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity. Journal of Medicinal Chemistry 1991; 34: 1272–1275
   PubMed Web of Science ®Google Scholar
• Cassidy M. K., Houston J. B. In vivo assessment of extrahepatic conjugative metabolism in first pass effects using the model compound phenol. Journal of Pharmacy and Pharmacology 1980; 32: 57–59
   PubMed Web of Science ®Google Scholar
• Cassidy K. M., Houston J. B. In vivo capacity of hepatic and extrahepatic enzymes to conjugate phenol. Drug Metabolism and Disposition 1984; 12: 619–624
   PubMed Web of Science ®Google Scholar
• Catwright P., Prys-Roberts C., Gill K., Stafford M., Gray A. Ventilatory depression related to plasma fentanyl concentrations during and after anesthesia in humans. Anesthesia and Analgesia 1983; 62: 966–975
   PubMed Web of Science ®Google Scholar
• Chamberlin D., Bossaert L., Carli P., Edgren E., Ekstrom L., Hapnes S., Holmberg S., Koster R., Linder K., Pasqualucci V., Perales N., Von Planta M., Robertson C., Steen P. Guidelines for advanced life support. Resuscitation 1992; 24: 111–121
   PubMed Web of Science ®Google Scholar
• Chan R. A., Benner E. J., Hoeprich P. D. Gentamicin therapy in real failure: a nomogram for dosage. Archives of Internal Medicine 1972; 76: 773–778
   Google Scholar
• Chang K. C., Laner B. A., Bell J. D., Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet 1978; i: 1132–1133
   Google Scholar
• Chapple D. J., Miller A. A., Ward J. B., Wheatley P. L. Cardiovascular and neurological effects of laudanosine: studies in mice, rats and in conscious and anaesthetised dogs. British Journal of Anaesthesia 1987; 59: 218–225
   PubMed Web of Science ®Google Scholar
• Chauvin M., Haberer J. P., Ferrier C., Trouvin J. H., Farinotti R., Duvaldestin P. Pharmacokinetics of midazolam in anesthetized cirrhotic patients. Anesthesiology 1987a; 67: A290
   Google Scholar
• Chauvin M., Sandouk P., Scherrmann J. M., Farinotti R., Strumza P., Duvaldestin P. Morphine pharmacokinetics in renal failure. Anesthesiology 1987b; 66: 327–331
   PubMed Web of Science ®Google Scholar
• Choonara I. A., Mc Kay P., Hain R., Rane A. Morphine metabolism in children. British Journal of Clinical Pharmacology 1989; 28: 599–604
   PubMed Web of Science ®Google Scholar
• Chopra D., Janson P., Sawin C. J. Insensitivity to digoxin associated with hypocalcemia. New England Journal of Medicine 1977; 296: 917–918
   PubMed Web of Science ®Google Scholar
• Cockshott I. D. Propofol (‘Diprivan’) pharmacokinetics and metabolism—an overview. Postgraduate Medical Journal 1985; 61: 45–50, Suppl. 3
   PubMed Web of Science ®Google Scholar
• Cook S., Palma O. Propofol as a sole sedative agent for prolonged infusion in intensive care. Journal of Drug Development 1989; 2(S2)65–67
   Google Scholar
• Coral I. M., Moore A. R., Strunin L. Plasma concentrations of fentanyl in normal surgical patients with severe renal failure. British Journal of Anaesthesia 1980; 52: 101P
   PubMed Web of Science ®Google Scholar
• Cottrell J. E., Robustelli A., Post K., Turndorf H. Furosemide and mannitol induced changes in intracranial pressure and serum osmolality and electrolytes. Anesthesiology 1977; 47: 28–30
   PubMed Web of Science ®Google Scholar
• Crul J. F., Long G. J., Brunner E. A., Coolen J. M. W. The changing pattern of neuromuscular blockade caused by succinylcholine in man. Anesthesiology 1966; 27: 729–741
   PubMed Web of Science ®Google Scholar
• Cumming J. F. The effect of arterial oxygen tension on antipyrine halftime in plasma. Clinical Pharmacology and Therapeutics 1976; 19: 468–470
   Web of Science ®Google Scholar
• Dahl J. B., Kehlet H. Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain. British Journal of Anaesthesia 1991; 66: 703–712
   PubMed Web of Science ®Google Scholar
• Dahms B. B., Halpin T. C. Pulmonary artery lipid deposit in new born infant receiving intravenous lipid infusion. Journal of Pediatrics 1980; 97: 800–805
   PubMed Web of Science ®Google Scholar
• Darragh A., Lambe R., Brick I., Downie W. W. Reversal of benzodiazepine-induced sedation by intravenous Ro 15–1788. Lancet 1981; ii: 1042
   Google Scholar
• Dissanayake V. U. K., Hughes J., Hunter J. C. Opioid binding sites in the guinea pig and rat kidney. Molecular Pharmacology 1991; 40: 93–100
   PubMed Web of Science ®Google Scholar
• Dogra S., Isaac P. A., Cockshott I. D., Foy J. M. Pulmonary extraction of propofol in post-cardiopulmonary bypass patients. Journal of Drug Development 1989; 2: 133
   Google Scholar
• Eddleston J. M., Shelly M. P. The effect on serum lipid concentrations of a prolonged infusion of propofol—hypertriglyceridaemia associated with propofol administration. Intensive Care Medicine 1991; 17: 424–426
   PubMed Web of Science ®Google Scholar
• Editorial., Stress ulcer prophylaxis in critically ill patients. Lancet 1989; ii: 1255–1256
   Google Scholar
• Edmunds R., West J. P. A study of the effect of vasopressin on portal and systemic blood pressure. Surgery, Gynecology and Obstetrics 1962; 114: 459–462
   Google Scholar
• Edwards J. D., Tweedle D. E. F. The haemodynamic effects of dopamine in severe human septic shock. British Journal of Surgery 1986; 73: 503
   Google Scholar
• Egawa K., Yoshida M., Kasai N. An endotoxin-induced serum factor that depresses hepatic δ-aminolevulinic acid synthetase activity and cytochrome P-450 levels in mice. Microbiology Immunology 1981; 25: 1091–1096
   PubMed Web of Science ®Google Scholar
• El Azhary R., Renton K. W., Mannering G. J. Effect of interferon inducing agents (polyriboinosinic acid, Polyribocytidylic acid and tilorone) on the heme turnover of hepatic cytochrome P450. Molecular Pharmacology 1980; 17: 395–399
   PubMed Web of Science ®Google Scholar
• Elin R. J., Vesell E. S., Wolff S. M. Effects of etiocholanolone induced fever on plasma antipyrine half lives and metabolic clearance. Clinical Pharmacology and Therapeutics 1975; 17: 447–457
   PubMed Web of Science ®Google Scholar
• Elliott S. L., Morgan D. J., Angus P. W., Ghabrial H., Smallwood R. A. The effect of hypoxia and acidosis on propanolol clearance in the isolated perfused rat liver preparation. Biochemical Pharmacology 1993a; 45: 763–765
   PubMed Web of Science ®Google Scholar
• Elliott S. L., Morgan D. J., Angus P. W., Ghabrial H., Watson R. G. P., Smallwood R. A. The effect of hypoxia on propanolol clearance during anterograde and retrograde flow in the isolated perfused rat liver preparation. Biochemical Pharmacology 1993b; 45: 573–578
   PubMed Web of Science ®Google Scholar
• Elston A. C., Bayliss M. K., Park G. R. Effect of renal failure on drug metabolism by the liver. British Jounal of Anaesthesia 1993; 71: 282–290
   PubMed Web of Science ®Google Scholar
• Farman J. V., Turner J., Blanloeil Y. Atracurium infusions in liver transplantation. British Journal of Anaesthesia 1986; 58: 96S–102S
   PubMed Web of Science ®Google Scholar
• Farrell G. C. Drug metabolism in extrahepatic disease. Pharmacology and Therapeutics 1987; 35: 375–404
   PubMed Web of Science ®Google Scholar
• Finck A. D., Berkowitz B. A., Hempstead B. S., Ngai S. H. Pharmacokinetics of morphine: effects of hypercarbia on serum and brain morphine concentrations in the dog. Anesthesiology 1977; 47: 407–410
   PubMed Web of Science ®Google Scholar
• Forbes G. B. Splenic lipidosis after administration of intravenous fat emulsions. Journal of Clinical Pathology 1978; 31: 765–771
   PubMed Web of Science ®Google Scholar
• Freud U., Krausz Y., Levij I. S., Eliakim M. Iatrogenic lipidosis following prolonged intravenous hyperalimentation. American Journal of Clinical Nutrition 1975; 28: 1156–1160
   PubMed Web of Science ®Google Scholar
• Fuller R., Hoppel C., Ingalls S. T. Furosemide kinetics in patients with hepatic cirrhosis and ascites. Clinical Pharmacology and Therapeutics 1981; 30: 461–467
   PubMed Web of Science ®Google Scholar
• Galant S. P., Duriseti L., Underwood S., Insel P. A. Decrease in β-adrenergic receptors on PMN leukocytes after adrenergic therapy. New England Journal of Medicine 1978; 299: 933–936
   PubMed Web of Science ®Google Scholar
• Geller E., Niv D., Silbiger A., Halpern P., Leykin Y., Rudick V., Sorkin P. Ro 15–1788 in the treatment of 34 intoxicated patients. Anesthesiology 1985; 63: A157
   PubMed Web of Science ®Google Scholar
• Geyer R. P., Watkin D. M., Mathews L. W., Stare F. Parenteral nutrition. XI. Studies with stable and unstable fat emulsions administered intravenously. Proceedings of the Society for Experimental Biology and Medicine 1951; 77: 872–876
   PubMed Web of Science ®Google Scholar
• Ghantous H., Lofberg B., Tjaive H., Danielsson B. R. G., Dencker L. Extrahepatic sites of metabolism of halothane in the rat. Pharmacology and Toxicology 1988; 62: 135–141, Abs
   PubMedGoogle Scholar
• Ghezzi P., Saccardo B., Bianchi M. Induction of xanthine oxidase and heme oxygenase and depression of liver drug metabolism by interferon: a study with different recombinant interferons. Journal of Interferon Research 1986a; 6: 251–256
   PubMedGoogle Scholar
• Ghezzi P., Saccardo B., Villa P., Rossi V., Bianchi M., Dinarrelo C. A. Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infection and Immunity 1986b; 54: 837–840
   PubMed Web of Science ®Google Scholar
• Gibson P. R., Dudley F. J. Ischemic hepatitis: clinical features, diagnosis and prognosis. Australian and New Zealand Journal of Medicine 1984; 14: 822–825
   PubMedGoogle Scholar
• Gladziwa U., Krishna D. R., Klotz U., Ittel T. H., Schunkert H., Glockner K., Mann H. Pharmacokinetics of ranitidine in patients undergoing haemofiltration. European Journal of Clinical Pharmacology 1988; 35: 427–430
   PubMed Web of Science ®Google Scholar
• Glaubiger G., Lefkowitz R. J. Elevated β-adrenergic receptor numbers after chronic propanolol treatment. Biochemistry Biophysical Research Communication 1977; 78: 720–725
   PubMed Web of Science ®Google Scholar
• Gleadle J., Varma N., Raggat P. R., Park G. R. Adrenal insufficiency in critically ill patients. Clinical Intensive Care 1993; 2: 104–105
   Google Scholar
• Golper T. A. Drug removal during continuous hemofiltration or hemodialysis. Contributions in Nephrology 1991; 93: 110–116
   PubMedGoogle Scholar
• Gonzalez M., Desager J.-P., Jacquemart J.-L., Chenu P., Muller T., Installe E. Efficacy of enoximone in the management of refractory low-output states following cardiac surgery. Journal of Cardiothoracic Anesthesia 1988; 2: 409–418
   PubMedGoogle Scholar
• Graves S. W., Brown B., Valdes R. An endogenous digoxin like substance in patients with renal impairment. Archives of Internal Medicine 1983; 99: 604–608
   Google Scholar
• Gray P. A., Park G. R. Chlormethiazole sedation for critical ill patients in renal failure. Anaesthesia 1989; 44: 913–915
   PubMed Web of Science ®Google Scholar
• Gray P., Park G. R. Plasma concentrations of dopexamine during the anhepatic period of liver transplantation. British Journal of Clinical Pharmacology 1993, in press
   PubMed Web of Science ®Google Scholar
• Gray P., Park G. R., Cockshott I. D., Douglas E. D., Shuker B., Simons P. J. Propofol metabolism in man during the anhepatic and reperfusion phases of liver transplantation. Xenobiotica 1992; 22: 105–114
   PubMed Web of Science ®Google Scholar
• Grebenik C. R., Hinds C. J. Management of the multiple organ donor. British Journal of Hospital Medicine 1987; 38: 62–65
   PubMed Web of Science ®Google Scholar
• Griffiths R. B., Hunter J. M., Jones R. S. Atracurium infusion in patients with renal failure on an ITU. Anaesthesia 1986; 41: 375–381
   PubMed Web of Science ®Google Scholar
• Grummitt R. M., Goat V. A. Intracranial pressure after phenoperidine. Anaesthesia 1984; 39: 565–567
   PubMed Web of Science ®Google Scholar
• Guay D. R. P., Awni W. H., Findlay J. W. A., Halstenson C. E., Abraham P. A., Opsahl J. A., Jones E. C., Matzke G. R. Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease. Clinical Pharmacology and Therapeutics 1988; 43: 63–71
   PubMed Web of Science ®Google Scholar
• Halliday N. J., Dundee J. W., Collier P. S., Loughran P. G., Harper K. W. Influence of plasma proteins on the onset of hypnotic action of intravenous midazolam. Anaesthesia 1985; 40: 763–766
   PubMed Web of Science ®Google Scholar
• Hanson K. M. Vascular response of intestine and liver to intravenous infusion of vasopressin. American Journal of Physiology 1970; 219: 779–784
   PubMed Web of Science ®Google Scholar
• Harper K. W., Collier P. S., Dundee J. W., Elliott P., Halliday N. J., Lowry K. G. Age and nature of operation influence the pharmacokinetics of midazolam. British Journal of Anaesthesia 1985; 57: 866–871
   PubMed Web of Science ®Google Scholar
• Harris H., Whittaker M. Differential inhibition of human serum cholinesterase with fluoride: recognition of two new phenotypes. Nature 1961; 191: 496–498
   PubMed Web of Science ®Google Scholar
• Hasselgren P. O., Biber B., Fornander U. Improved blood flow and protein synthesis in the postischemic liver following infusion of dopamine. Journal of Surgical Research 1983; 34: 44–52
   PubMed Web of Science ®Google Scholar
• Hasselgren P. O., Fischer J. E. Septic encephalopathy. Intensive Care Medicine 1986; 12: 13–16
   PubMed Web of Science ®Google Scholar
• Heinemeyer G., Link J., Weber W., Meschede V., Roots I. Clearance of ceftriaxone in critical care patients with acute renal failure. Intensive Care Medicine 1990; 16: 448–453
   PubMed Web of Science ®Google Scholar
• Heizmann P., Von Alten R. Determination of midazolam and its hydroxymetabolite in plasma by gas chromatography with electron capture detection. High Resolution Chromatography 1981; 4: 266–269
   Google Scholar
• Helmers H., Vanpeer A., Woestenborghs R., Noorduin H., Heykants J. Alfentanil pharmacokinetics in elderly patients. Clinical Pharmacology and Therapeutics 1984; 36: 239–243
   PubMed Web of Science ®Google Scholar
• Hessov I., Melsen F., Haug A. Postmortem findings in three patients with intravenous fat emulsions. Archives of Surgery 1979; 114: 66–68
   PubMedGoogle Scholar
• Heyman M. B., Storch S., Ament M. E. The fat overload syndrome. American Journal of Diseases of Children 1981; 135: 628–630
   PubMedGoogle Scholar
• Hill S. A., Quinn K., Shelly M. P., Park G. R. Reversible renal failure following opioid administration. Anaesthesia 1991; 46: 938–939
   PubMed Web of Science ®Google Scholar
• Hiller A., Olkkola K. T., Isohanni P., Saarnivaara L. Unconsciousness associated with midazolam and erythromycin. British Journal of Anaesthesia 1990; 65: 826–828
   PubMed Web of Science ®Google Scholar
• Hoffman B. B., Lefkowitz R. J. Catecholamines and sympathomimetic drugs. The Pharmacological Basis of Therapeutics8th Edn, A. Goodman, T. W. Gilman, A. S. Rall, P. Nies, P. Taylor. McGraw-Hill, New York 1990; 187–220
   Google Scholar
• Holaday J. W., Faden A. I. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 1978; 275: 450–451
   PubMed Web of Science ®Google Scholar
• Holley F. O., Ponganis K. V., Stanski D. R. Effects of cardiac surgery with cardiopulmonary bypass on lidocaine disposition. Clinical Pharmacology and Therapeutics 1984; 35: 617–626
   PubMed Web of Science ®Google Scholar
• Hulman G., Pearson H. J., Fraser I., Fraser P. R. F. Agglutination of intralipid by sera of acutely ill patients. Lancet 1982; ii: 1426–1427
   Google Scholar
• Imaoka S., Fujita S., Funae Y. Age-dependent expression of cytochrome P-450s in rat liver. Biochimica et Biophysica Acta 1991; 1097: 187–192
   PubMed Web of Science ®Google Scholar
• Isherwood C. N., Calvey T. N., Williams N. E., Chan K., Murray G. R. Elimination of phenoperidine in liver disease. British Journal of Anaesthesia 1984; 56: 843–846
   PubMed Web of Science ®Google Scholar
• Janssen U., Walker S., Maier K., Von Gaisberg U., Klotz U. Flumazenil disposition and elimination in cirrhosis. Clinical Pharmacology and Therapeutics 1989; 46: 317–323
   PubMed Web of Science ®Google Scholar
• Johansson I., Lindros K. O., Erikasson H., Ingelman-Sundberg M. Transcriptional control of CYP 2E1 in the perivenous liver region and during starvation. Biochemistry Biophysical Research Communication 1990; 173: 331–338
   PubMed Web of Science ®Google Scholar
• Jones D. P. Hypoxia and drug metabolism. Biochemical Pharmacology 1981; 30: 1019–1023
   PubMed Web of Science ®Google Scholar
• Jones D. P., Mason H. S. Gradients of O2 concentration in hepatocytes. Journal of Biological Chemistry 1978; 253: 4874–4880
   PubMed Web of Science ®Google Scholar
• Jorfeldt L., Lewis D. H., Lofstrom J. R., Post C. Lung uptake of lidocaine in healthy volunteers. Acta Anaesthesiologica Scandinavica 1979; 23: 567–574
   PubMed Web of Science ®Google Scholar
• Jorfeldt L., Lewis D. H., Loftstrom J. B., Post C. Lung uptake of lidocaine in man as influenced by anaesthetics, mepivicaine infusion or lung insufficiency. Acta Anaesthesiologica Scandinavica 1983; 27: 5–9
   PubMed Web of Science ®Google Scholar
• Kalow W., Genest K. A method for the detection of atypical forms of human and physiology serum cholinesterase: determination of dibucaine numbers. Canadian Journal of Biochemistry and Physiology 1957; 35: 339–343
   PubMedGoogle Scholar
• Kanazawa Y., Kitada M., Mori T. Ascorbic acid deficiency decreases specific forms of cytochrome P-450 in liver microsomes of guinea pigs. Molecular Pharmacology 1991; 39: 456–460
   PubMed Web of Science ®Google Scholar
• Kaplan S. A., Jack M. A. Pharmacokinetics and metabolism of anxiolytics. Handbook of Experimental Pharmacology55th Edn, L. Hoffmeister. Springer-Verlag, Heidelberg 1981; 321–358
   Google Scholar
• Kleinberger G., Grimm G., Laggner A., Druml W., Lenz K., Schneeweiss B. Weaning patients from mechanical ventilation by benzodiazepine antagonist Ro15–1788. Lancet 1985; ii: 268–269
   Google Scholar
• Klotz U., Avant G. R., Wilkinson G. R., Hoyumpa A., Schenkers S. Altered disposition and elimination of diazepam in patients with liver disease. Gastroenterology 1973; 65: 552
   Web of Science ®Google Scholar
• Klotz U., Mc Horse T. S., Wilkinson G. R., Schenker S. The effect of cirrhosis on the disposition and elimination of meperidine in man. Clinical Pharmacology and Therapeutics 1974; 16: 675–677
   Web of Science ®Google Scholar
• Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E. APACHE II: a severity of disease classification. Critical Care Medicine 1985; 13: 818–829
   PubMed Web of Science ®Google Scholar
• Knell A. J., Turner P., Chalmers E. P. D. Potential hazard of steroid anaesthesia for prolonged sedation. Lancet 1983; i: 526
   Google Scholar
• Kolars J. C., Awni W. M., Merion R. M., Watkins P. B. First-pass metabolism of cyclosporin by the gut. Lancet 1991; 338: 1488–1489
   PubMed Web of Science ®Google Scholar
• Kong K. L., Tyler J. E., Willatts S. M., Prys-Roberts C. Isoflurane sedation for patients undergoing mechanical ventilation: metabolism to inorganic fluoride and renal effects. British Journal of Anaesthesia 1990; 64: 159–162
   PubMed Web of Science ®Google Scholar
• Kong K. L., Willatts S. M., Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. British Medical Journal 1989; 298: 1277–1279
   PubMed Web of Science ®Google Scholar
• Kopin I. J. Catecholamine metabolism (and the biochemical assessment of sympathetic activity). Clinical Endocrinology and Metabolism 1977; 6: 525–549
   PubMedGoogle Scholar
• Kraus J. W., Desmond P. V., Marshall J. P., Johnson R. F., Schenker S., Wilkinson G. R. Effects of aging and liver disease on disposition of lorazepam. Clinical Pharmacology and Therapeutics 1978; 24: 411–419
   PubMed Web of Science ®Google Scholar
• Ledingham Mc I. A., Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1983; i: 1270
   Google Scholar
• Lehmann H., Silk E. Succinyl monocholine. British Medical Journal 1953; 1: 767–768
   PubMed Web of Science ®Google Scholar
• Letarte L., Du Souich P. Influence of hypercapnia and/or hypoxaemia and metabolic acidosis on theophylline kinetics in the conscious rabbit. American Review of Respiratory Diseases 1984; 129: 762–766
   PubMed Web of Science ®Google Scholar
• Levene M. I., Wigglesworth J. S., Desai R. Pulmonary fat accumulation after intralipid infusion in the preterm infant. Lancet 1980; ii: 815–818
   Google Scholar
• Lloyd-Thomas A. R., Booker P. D. Infusion of midazolam in pediatric patients after cardiac surgery. British Journal of Anaesthesia 1986; 58: 1109–1115
   PubMed Web of Science ®Google Scholar
• Luprian K. G., Churchil-Davison H. C. Effect of suxamethonium on cardiac rhythm. British Medical Journal 1960; 2: 1774–1777
   PubMed Web of Science ®Google Scholar
• Lynam D. P., Cronnelly R., Castagnoli K. P., Claver Cranfell P., Caldwell J., Arden J., Miller R. D. The pharmacodynamics and pharmacokinetics of vecuronium in patients anaesthetized with isoflurane with normal renal function or with renal failure. Anesthesiology 1988; 69: 227–231
   PubMed Web of Science ®Google Scholar
• Lynn A. M., Slattery J. T. Morphine pharmacokinetics in early infancy. Anesthesiology 1987; 66: 136–139
   PubMed Web of Science ®Google Scholar
• Mac Nab M. S. P., Mac Rae O. J., Guy E., Grant I. S., Feely J. Profound reduction in morphine clearance and liver blood flow in shock. Intensive Care Medicine 1986; 12: 366–369
   PubMed Web of Science ®Google Scholar
• Maestracci P., Grimaud D., Livrelli N., Philip F., Dolisi C. Increase in hepatic blood flow and cardiac output during dopamine infusion in man. Critical Care Medicine 1981; 9: 14–16
   PubMed Web of Science ®Google Scholar
• Mather L. E. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clinical Pharmacokinetics 1983; 8: 422–446
   PubMed Web of Science ®Google Scholar
• Mazoit J. X., Sandouk P., Zetalaoui P., Scherrmann J. M. Pharmacokinetics of unchanged morphine in normal and cirrhotic subjects. Anesthesia and Analgesia 1987; 66: 293–298
   PubMed Web of Science ®Google Scholar
• Mazze R. I., Calverley R. K., Smith N. T. Inorganic fluoride nephrotoxicity. Anesthesiology 1977; 46: 265–271
   PubMed Web of Science ®Google Scholar
• Mc Clain D. A., Hug C. C. Intravenous fentanyl kinetics. Clinical Pharmacology and Therapeutics 1980; 28: 106–114
   PubMed Web of Science ®Google Scholar
• Mc Donald C. F. M., Thomson S. A., Scott N. C., Scott W., Grant I. W. B., Crompton G. K. Benzodiazepine-opiate antagonism—a problem in intensive-care therapy. Intensive Care Medicine 1986; 12: 39–42
   PubMed Web of Science ®Google Scholar
• Mc Innes G. T. The value of therapeutic drug monitoring to the practising physician—an hypothesis in need of testing. British Journal of Clinical Pharmacology 1989; 27: 281–284
   PubMed Web of Science ®Google Scholar
• Mc Leod G. A., Pace N., Inglis M. D. Bacterial growth in propofol. British Journal of Anaesthesia 1991; 67: 665–666
   PubMed Web of Science ®Google Scholar
• Mc Quay H. J., Bullingham R. E. S., Moore R. A. Acute opiate tolerance in man. Life Sciences 1981; 28: 2513–2517
   PubMed Web of Science ®Google Scholar
• Mc Quay H. J., Moore R. A. Metabolism of narcotics. British Medical Journal 1984; 288: 237
   Google Scholar
• Mhaire M. C., Ticku M. K. Chronic ethanol administration alters GABA-A receptor gene expression. Molecular Pharmacology 1992; 42: 415–422
   PubMed Web of Science ®Google Scholar
• Miahin V., Von Bahr C., Ingelman-Sundberg M. Chlormethiazole as a potent and selective inhibitor in vivo of CYP2E1 during food deprivation. Abstract Presented at the First International Conference on Food Nutrition and Chemical Toxicity. GuildfordUK 1991
   Google Scholar
• Mistry M., Houston J. B. Glucuronidation in vitro and in vivo: comparison of intestinal and hepatic conjugation of morphine, naloxone and buprenorphine. Drug Metabolism and Disposition 1987; 15: 710–717
   PubMed Web of Science ®Google Scholar
• Mitchell M. D., Wilson J., Dodek P., Russel J. Volume distribution in patients with Gram-negative sepsis in the ICU. Anesthesiology 1987; 67: A126
   Google Scholar
• Modig J. Indications of chlormethiazole as a protective agent in experimental endotoxaemia. European Surgical Research 1988; 20: 195–204
   PubMed Web of Science ®Google Scholar
• Moochhala S. M., Renton K. W. Effects of the interferon inducing agent, Polyrl.rC on the synthesis of hepatic cytochrome P450. Asia Pacific Journal of Pharmacology 1989; 4: 83–88
   Google Scholar
• Moore R. D., Smith C. R., Leitman P. S. Association of aminoglycoside levels with therapeutic outcome in Gram-negative pneumonia. American Journal of Medicine 1984; 77: 657–662
   PubMed Web of Science ®Google Scholar
• Morgan E. T. Suppression of constitutive cytochrome P450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Molecular Pharmacology 1989; 36: 699–707
   PubMed Web of Science ®Google Scholar
• Morgan E. T., Norman C. A. Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers. Drug Metabolism and Disposition 1990; 18: 649–653
   PubMed Web of Science ®Google Scholar
• Morley J. S., Miles J. B., Wells J. C., Bowsher D. Paradoxical pain. Lancet 1992; 340: 1045
   PubMed Web of Science ®Google Scholar
• Motulsky H. J., Insel P. A. Adrenergic receptors in man. New England Journal of Medicine 1982; 307: 18–29
   PubMed Web of Science ®Google Scholar
• Moudgil G. C. Effect of premedicants, intravenous anaesthetic agents and local anaesthetics on phagocytosis. in vitro. Canadian Anaesthetists' Journal 1981; 28: 597–601
   PubMedGoogle Scholar
• Mukherjee C., Caron M. G., Lefkowitz R. J. Catecholamine induced subsensitivity of adenylate cyclase associated with loss of β-adrenergic receptor binding sites. Proceedings of the National Academy of Science, USA 1975; 72: 1945–1949
   PubMed Web of Science ®Google Scholar
• Nattel S., Gagne G., Pineau M. The pharmacokinetics of lignocaine and β-adrenreceptor antagonists in patients with acute myocardial infarction. Clinical Pharmacokinetics 1987; 13: 293–316
   PubMed Web of Science ®Google Scholar
• Nunn J. Clinical aspects of the interaction between nitrous oxide and vitamin B12. British Journal of Anaesthesia 1987; 59: 3–13
   PubMed Web of Science ®Google Scholar
• Nunn J. F., Chanarin I., Tanner A. G., Owen F. R. Megaloblastic bone marrow changes after repeated nitrous oxide anaesthesia: reversal with folinic acid. British Journal of Anaesthesia 1986; 58: 1469–1470
   PubMed Web of Science ®Google Scholar
• O'Sullivan G., Park G. R. The assessment of sedation. Journal of Clinical Intensive Care 1990; 1: 116–122
   Google Scholar
• Odar-Cederlof I., Borga O. Kinetics of diphenylhydantoin in uremic patients: consequences of decreased plasma protein binding. European Journal of Clinical Pharmacology 1974; 7: 31–37
   PubMed Web of Science ®Google Scholar
• Oetgen W. J., Sobol S. M., Tri T. B. Amiodarone-digoxin interaction: clinical and experimental observations. Chest 1984; 86: 75–79
   PubMed Web of Science ®Google Scholar
• Osborne R. J., Joel S. P., Slevin M. L. Morphine intoxication in renal failure: the role of morphine 6-glucuronide. British Medical Journal 1986; 292: 1548–1549
   PubMed Web of Science ®Google Scholar
• Pacifici G. M., Rane A. Inhibition of morphine glucuronidation by oxazepam in human fetal liver microsomes. Drug Metabolism and Disposition 1981; 9: 569–572
   PubMed Web of Science ®Google Scholar
• Park G. R. Ethical and moral difficulties with trials in intensive care. Intensive Care World 1989; 6: 11–12
   Google Scholar
• Park G. R., Couzens S., Hoskins R. D. Effects of inotropes on platelet numbers and function. Clinical Intensive Care 1992; 3: 160–165
   Google Scholar
• Park G. R., Elston A. What controls drug metabolism in the critically ill patient?. Care of the Critically Ill 1991; 7: 212
   Google Scholar
• Park G. R., Gray P. A. Infusions of analgesics, sedatives and muscle relaxants in patients requiring intensive care. Anaesthesia 1989; 44: 879–880
   PubMed Web of Science ®Google Scholar
• Park G. R., Manara A. R., Dawling S. Extrahepatic metabolism of midazolam. British Journal of Clinical Pharmacology 1989a; 27: 633–634
   Web of Science ®Google Scholar
• Park G. R., Pichard L., Tinel M., Larroque C., Elston A., Domerque J., Dexionne B., Maurel P. What changes drug metabolism in critically ill patients? Two preliminary studies in isolated hepatocytes. Anaesthesia 1993, in press
   Web of Science ®Google Scholar
• Park G. R., Podkowik A. Plasma concentrations of flumazenil during liver transplantation. Anaesthesia 1992; 47: 887–889
   PubMed Web of Science ®Google Scholar
• Park G. R., Shelly M. P., Quinn K., Roberts P. Dihydrocodeine: a reversible cause of renal failure?. European Journal of Anaesthesiology 1989b; 6: 303–314
   PubMed Web of Science ®Google Scholar
• Parker S. G., Thomas D. G. Dihydrocodeine overdose treated with naloxone infusion. British Medical Journal 1983; 287: 1547
   PubMedGoogle Scholar
• Perkins M. W., Dasta J. F., Dehaven B. Physiologic implications of mechanical ventilation on pharmacokinetics. Annals of Pharmacotherapy 1989; 23: 316–323
   Web of Science ®Google Scholar
• Persson M. P., Wiklund L., Hartvig P., Paalzow L. The potential pulmonary uptake and clearance of morphine in postoperative patients. European Journal of Clinical Pharmacology 1986; 30: 567–574
   PubMed Web of Science ®Google Scholar
• Perttunen K., Kalso E., Heinonen J., Salo J. I.v. diclofenac in post-thoracotomy pain. British Journal of Anaesthesia 1992; 68: 474–480
   PubMed Web of Science ®Google Scholar
• Pollack G. M., Browne J. L., Marton J., Haberer L. J. Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat. Drug Metabolism and Disposition 1991; 19: 130–134
   PubMed Web of Science ®Google Scholar
• Power I., Cumming A. D., Pugh G. C. Effects of diclofenac on renal function and prostacyclin generation after surgery. British Journal of Anaesthesia 1992; 69: 451–456
   PubMed Web of Science ®Google Scholar
• Prescott L. F., Adjepon-Yamoah K. K., Talbot R. J. Impaired lidocaine metabolism in patients with myocardial infarction and cardiac failure. British Medical Journal 1976; 1: 939–941
   PubMed Web of Science ®Google Scholar
• Rane A., Gawronska-Szklarz B., Svensson J. Natural(-)- and unnatural(+)-enantiomers of morphine: comparative metabolism and effect of morphine and phenobarbital treatment. Journal of Pharmacology and Experimental Therapeutics 1985; 234: 761–765
   PubMed Web of Science ®Google Scholar
• Redfern N. Dihydrocodeine overdose treated with naloxone infusion. British Medical Journal 1983; 287: 751–752
   PubMed Web of Science ®Google Scholar
• Reeves J. G. Benzodiazepines. Pharmacokinetics of Anaesthesia, C. Prys-Roberts, C. C. Hug. Blackwell, Oxford 1984; 157–186
   Google Scholar
• Reidenberg M. M. The biotransformations of drugs in renal failure. American Journal of Medicine 1977; 62: 482–485
   PubMed Web of Science ®Google Scholar
• Reves J. G., Fragen R. J., Vinik R., Greenblatt D. J. Midazolam: pharmacology and uses. Anesthesiology 1985; 62: 310–324
   PubMed Web of Science ®Google Scholar
• Roberts A. P., Harrison C., Dixon G. T., Curtis J. R. Plasma ranitidine concentrations after intravenous administration in normal volunteers and haemodialysis patients. Postgraduate Medical Journal 1983; 59: 25–27
   PubMed Web of Science ®Google Scholar
• Rodgers E. M. Diprivan intensive care sedation in children. British Journal of Anaesthesia 1991; 67: 505
   PubMed Web of Science ®Google Scholar
• Roerig D. L., Kortly K. J., Vucins E. G., Ahlf S. B., Dawson C. A., Kampine J. P. First pass uptake of fentanyl, meperidine and morphine in the human lung. Anesthesiology 1987; 67: 466–472
   PubMed Web of Science ®Google Scholar
• Routledge P. A., Bartlowsky A., Bjornsson T. D., Kitchall B. B., Shand D. G. Lidocaine plasma protein binding. Clinical Pharmacology and Therapeutics 1980; 27: 347–354
   PubMed Web of Science ®Google Scholar
• Schentag J. J., Jusko W. J. Renal clearance and tissue accumulation of gentamicin. Clinical Pharmacology and Therapeutics 1977; 22: 364–370
   PubMed Web of Science ®Google Scholar
• Schumach G. E. Pharmacokinetic analysis of gentamicin dosage regimes for renal impairment. Journal of Clinical Pharmacology 1975; 15: 656–665
   PubMed Web of Science ®Google Scholar
• Scott D. B., Beamish D., Hudson I. N., Jostell K.-G. Prolonged infusion of chlorme-thiazole in intensive care. British Journal of Anaesthesia 1980; 52: 541–545
   PubMed Web of Science ®Google Scholar
• Sear J. W., Fisher A., Summerfield R. J. Is alfentanil by infusion useful for sedation on the ITU. European Journal of Anaesthesiology 1987; S1: 55–61
   Google Scholar
• Secor J. W., Echenker S. Drug metabolism in patients with liver disease. Advances in Internal Medicine 1987; 32: 379–406
   PubMedGoogle Scholar
• Segredo V., Caldwell J. E., Matthay M. A., Sharma M. L., Gruenke L. D., Miller R. D. Persistent paralysis in critical ill patients after long-term administration of vecuronium. New England Journal of Medicine 1992; 327: 524–528
   PubMed Web of Science ®Google Scholar
• Serbource-Goguel N., Durand G., Corbic M., Agneray J., Feger J. Alterations in relative proportions of microheterogeneous forms of human 1-acid glycoprotein in liver disease. Journal of Hepatology 1986; 2: 245–252
   PubMed Web of Science ®Google Scholar
• Sha M., Saito Y., Yokoyama K., Sawa T., Amaha K. Effects of continuous positive pressure ventilation on hepatic blood flow and intrahepatic oxygen delivery in dogs. Critical Care Medicine 1987; 15: 1040–1043
   PubMed Web of Science ®Google Scholar
• Shafer A. A., White P. F., Schuttler J., Rosenthal M. H. Use of fentanyl infusion in the intensive care unit: tolerance to its anesthetic effects. Anesthesiology 1983; 59: 245–248
   PubMed Web of Science ®Google Scholar
• Shan X., Aw T. Y., Smith E. R., Ingelman-Sunberg M., Mannervik B., Iyanagi T., Jones D. P. Effect of chronic hypoxia on detoxification enzymes in rat liver. Biochemical Pharmacology 1992; 43: 2421–2426
   PubMed Web of Science ®Google Scholar
• Shedlofsky S. I., Swim A. T., Robinson J. M., Gallicchio V. S., Cohen D. A., Mc Clain C. J. Interleukin-1 (IL1) depresses cytochrome P450 levels and activity in mice. Life Sciences 1987; 40: 2331–2336
   PubMed Web of Science ®Google Scholar
• Shelly M. P., Cory E. P., Park G. R. Pharmacokinetics of morphine in two children before and after liver transplantation. British Journal of Anaesthesia 1986; 58: 1218–1223
   PubMed Web of Science ®Google Scholar
• Shelly M. P., Park G. R., Mendel L. Failure of critically ill patients to metabolise midazolam. Anaesthesia 1987; 42: 619–626
   PubMed Web of Science ®Google Scholar
• Shelly M. P., Sultan M. A., Bodenham A., Park G. R. Midazolam infusions in critically ill patients. European Journal of Anaesthesiology 1991; 8: 21–27
   PubMed Web of Science ®Google Scholar
• Shelly M. P., Walker S., Park G. R. The pharmacokinetics of alfentanil in patients following liver transplantation. Advances in the Biosciences 1989; 75: 643–646
   Google Scholar
• Shilo L., Shapiro M. S., Doler S., Shenkman L. Endogenous digoxin like material in patients with liver disease. Archives of Internal Medicine 1985; 103: 643
   Google Scholar
• Shoemaker W. C., Appel P. L., Kram H., Waxman K. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94: 811–833
   PubMed Web of Science ®Google Scholar
• Silva Y. J., Moffat R. C., Walt A. J. Vasopressin effect on portal and systemic hemodynamics. Journal of the American Medical Association 1969; 210: 1065–1068
   PubMed Web of Science ®Google Scholar
• Skacel P. O., Hewlett A. M., Lewis J. D., Lumb M., Nunn J. F., Chanarin I. Studies on the haemopoietic toxicity of nitrous oxide in man. British Journal of Haematology 1983; 53: 189–200
   PubMed Web of Science ®Google Scholar
• Sotaniemi E., Arvela P., Huhti E. Increased clearance of tolbutamide from the blood of asthmatic patients. Annals of Allergy 1971a; 29: 139–141
   PubMedGoogle Scholar
• Sotaniemi E., Arvela P., Huhti E., Koivisto O. Half-life of tolbutamide in patients with chronic respiratory failure. European Journal of Clinical Pharmacology 1971b; 4: 29–31
   PubMed Web of Science ®Google Scholar
• Spencer E. M., Willatts S. M. Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Medicine 1992; 18: 415–421
   PubMed Web of Science ®Google Scholar
• Spencer M. E., Willatts S. M., Prys-Roberts C. Plasma inorganic fluoride concentrations during and after prolonged (>24h) Isolorane sedation: effect on renal function. Anesthesia and Analgesia 1991; 73: 731–737
   PubMed Web of Science ®Google Scholar
• Stevenson I. H., Dutton G. J. Glucuronide synthesis in kidney and gastrointestinal tract. Biochemical Journal 1962; 82: 330–339, Abs
   PubMed Web of Science ®Google Scholar
• Sujita K., Okuno F., Hirano Y., Inamoto Y., Eto S., Arai M. Effect of interleukin 1 (IL-1) on the levels of cytochrome P450 involving IL-1 receptor on the isolated hepatocytes of rat. Biochemical and Biophysical Research Communications 1990; 168: 1217–1222
   PubMed Web of Science ®Google Scholar
• Szeto H. H., Inturrisi C. E., Houde R., Saal S., Cheigh J., Reidenberg M. M. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer. Annals of Internal Medicine 1977; 86: 738–741
   PubMed Web of Science ®Google Scholar
• Thompson P. D., Melmon K. L., Richardson J. A., Cohn K., Steinbrunn W., Cudihee R., Rowland M. Lidocaine pharmacokinetics in advanced heart failure, liver failure and renal failure in human. Annals of Internal Medicine 1973; 78: 499–508
   PubMed Web of Science ®Google Scholar
• Tilstone W. J., Fine A. Furosemide kinetics in renal failure. Clinical Pharmacology and Therapeutics 1978; 23: 644–650
   PubMed Web of Science ®Google Scholar
• Townsend M. C., Schirmer W. J., Schirmer J. M., Fry D. E. Low dose dopamine improves effective hepatic blood flow in murine peritonitis. Circulatory Shock 1987; 21: 149–153
   PubMedGoogle Scholar
• Trenholme G. M., Williams R. L., Rieckmann K. H., Frischer H., Carson P. E. Quinine disposition during malaria and during induced fever. Clinical Pharmacology and Therapeutics 1976; 19: 459–467
   PubMed Web of Science ®Google Scholar
• Tsutsumi M., Lasker J. M., Shimizu M., Rosman A. S., Lieber C. S. The intralobular distribution of ethanol-inducible P450 IIEI in rat and human liver. Hepatology 1989; 10: 437–446
   PubMed Web of Science ®Google Scholar
• Tubaro E., Borelli G., Croce C., Cavallo G., Santiangeli C. Effect of morphine on resistance to infection. Journal of Infectious Diseases 1983; 148: 656–666
   PubMed Web of Science ®Google Scholar
• Van Der Rijt C. C. D., Drost R. H., Schalm S. W., Schramel M. Pharmacokinetics of flumazenil in fulminant hepatic failure. European Journal of Clinical Pharmacology 1991; 41: 501
   PubMed Web of Science ®Google Scholar
• Varma N., Park G. R. Steroid treatment in the critically ill. Clinical Intensive Care 1991; 2: 68–70
   Google Scholar
• Verbefck R., Tjandramaga T. B., Verberckmoes R., Deschepper P. J. Biotransformation and excretion of lorazepam in patients with chronic renal failure. British Journal of Clinical Pharmacology 1976; 3: 1033–1039
   PubMed Web of Science ®Google Scholar
• Vinik H. R., Reves J. G., Greenblatt D. J., Abernethy D. R., Smith L. R. The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology 1983; 59: 390–394
   PubMed Web of Science ®Google Scholar
• Warren S. E., Blantz R. C. Mannitol. Archives of Internal Medicine 1981; 141: 493–497
   PubMedGoogle Scholar
• Watson I. D., Thomson A. H. The value of therapeutic drug monitoring to the practising physician—an hypothesis needing sensible application. British Journal of Clinical Pharmacology 1989; 28: 619–620
   PubMed Web of Science ®Google Scholar
• Watt I., Mc I., Ledingham A. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984; 39: 973–981
   PubMed Web of Science ®Google Scholar
• Weber J. A., Van Zanten A. P. Interferences in current methods for measurements of creatinine. Clinical Chemistry 1991; 37: 695–700
   PubMed Web of Science ®Google Scholar
• Wesson D. E., Rich R. H., Zlotkin S. D. H., Pencharz P. B. Fat overload syndrome causing respiratory insufficiency. Journal of Pediatric Surgery 1984; 19: 777–778
   PubMed Web of Science ®Google Scholar
• Whang R., Oei T. O., Wantanabe A. Frequency of hypomagnesemia in hospitalised patients receiving digitalis. Archives of Internal Medicine 1985; 145: 655–656
   PubMedGoogle Scholar
• Whittacker M., Britten J. J., Wicks R. J. Inhibition of the plasma cholinesterase variants by propranolol. British Journal of Anaesthesia 1981; 53: 511–516
   PubMed Web of Science ®Google Scholar
• Whitwam J. G., Morgan M., Hall G. M., Petrie A. Pain during continuous nitrous oxide administration. British Journal of Anaesthesia 1976; 48: 425–428
   PubMed Web of Science ®Google Scholar
• Wilkinson G. R. The effects of liver disease and aging on the disposition of diazepam, chlor-diazepoxide, oxazepam and lorazepam in man. Acta Psychiatrica Scandinavica 1978; 59: 56–74, Suppl. 274
   Google Scholar
• Williams R. L., Blaschke T. F., Meffin P. J., Melmon K. L., Rowland M. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green. Clinical Pharmacology and Therapeutics 1976; 20: 290–299
   PubMed Web of Science ®Google Scholar
• Yate P. M., Thomas D., Short S. M., Sebel P. S., Morton J. Comparison of infusions of alfentanil or pethidine for sedation of ventilated patients on the ITU. British Journal of Anaesthesia 1986; 58: 1091–1099
   PubMed Web of Science ®Google Scholar
• Yun Y., Casazza J. P., Sohn D. H., Veech R. L., Song B. J. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet. Molecular Pharmacology 1992; 41: 474–479
   PubMed Web of Science ®Google Scholar
• Zeigler E. J., Fisher C. J., Sprung C. L., Sadoff J. C., Foulke G. E., Wortel C. H., Fink M. P., Dellinger P., Teng N. N. H., Allen I. E., Berger H. J., Knatterud G. L., Lobuglio A. F., Smith C. R. Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant. Escherichia coli. New England Journal of Medicine 1991; 324: 429–436
   PubMed Web of Science ®Google Scholar